OOIR: Observatory of International Research

Papers

(The H4-Index of eBioMedicine is 74. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients	1166
CAR-NK cells: A promising cellular immunotherapy for cancer	411
Vascular occlusion by neutrophil extracellular traps in COVID-19	353
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development	284
Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology	281
Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?	276
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients	265
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity	218
SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta	179
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies	170
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection	165
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial	153
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients	144
Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study	143
CAR-T design: Elements and their synergistic function	141
Mitochondria in acute myocardial infarction and cardioprotection	139
Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study	138
Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression	138
Intranasal COVID-19 vaccines: From bench to bed	135
Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract	134
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR	132
Genetics of mitochondrial diseases: Identifying mutations to help diagnosis	132
Therapeutic targeting of “undruggable” MYC	131
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity	129
Lactate in the tumour microenvironment: From immune modulation to therapy	129

Host genetic factors determining COVID-19 susceptibility and severity	124
A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility	123
Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank	120
Microplastics detected in cirrhotic liver tissue	120
Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain	119
Emerging SARS-CoV-2 variants expand species tropism to murines	118
Characterizing Long COVID: Deep Phenotype of a Complex Condition	118
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity	112
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series	112
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients	111
Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours	109
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy	107
The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)	106
Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation	106
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses	106
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies	106
SARS-CoV-2 detection in different respiratory sites: A systematic review and meta-analysis	106
Reappearance of effector T cells is associated with recovery from COVID-19	104
Stimuli-responsive prodrug-based cancer nanomedicine	102
Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up	102
Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice	101
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies	100
Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression	99
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters	96
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machi	95
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development	94
Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study	94
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion	93
Kidney damage causally affects the brain cortical structure: A Mendelian randomization study	92
Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis	92
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong	90
Epigenome-wide association study of COVID-19 severity with respiratory failure	90
The gut virome: A new microbiome component in health and disease	89
Attention is not all you need: the complicated case of ethically using large language models in healthcare and medicine	87
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France	86
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma	85
SARS-CoV-2 leads to a small vessel endotheliitis in the heart	85
Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis	84
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model	83
Circulating tumor cell isolation for cancer diagnosis and prognosis	82
Interactions between neutrophil extracellular traps and activated platelets enhance procoagulant activity in acute stroke patients with ICA occlusion	82
Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy	79
Clinical features and prognostic factors in Covid-19: A prospective cohort study	78
Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS	78
Machine learning for brain age prediction: Introduction to methods and clinical applications	76
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants	76
Infectivity of human coronavirus in the brain	74
Macrophage phenotypic switch orchestrates the inflammation and repair/regeneration following acute pancreatitis injury	74
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model	74
Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study	74

Deep-learning-assisted detection and segmentation of rib fractures from CT scans: Development and validation of FracNet